Pages that link to "Q37736260"
The following pages link to Therapeutic antibodies for autoimmunity and inflammation (Q37736260):
Displaying 50 items.
- Zika Virus: Medical Countermeasure Development Challenges (Q24261184) (← links)
- Inhaled protein/peptide-based therapies for respiratory disease (Q26751439) (← links)
- Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? (Q26765043) (← links)
- The role of Fc-FcγR interactions in IgG-mediated microbial neutralization (Q26797466) (← links)
- The expanding role of immunopharmacology: IUPHAR Review 16 (Q26801862) (← links)
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics (Q26822421) (← links)
- Pharmacokinetic/pharmacodynamic modeling in inflammation (Q26830621) (← links)
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis (Q27001736) (← links)
- In vivo binding and retention of CD4-specific DARPin 57.2 in macaques (Q27320871) (← links)
- CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes (Q27341786) (← links)
- Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins (Q28072319) (← links)
- An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis (Q28079322) (← links)
- A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief (Q28240662) (← links)
- Designing cell-targeted therapeutic proteins reveals the interplay between domain connectivity and cell binding (Q28252009) (← links)
- Antibody therapy of cancer (Q28262538) (← links)
- Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activity (Q28487387) (← links)
- High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region (Q28709119) (← links)
- FcRn overexpression in transgenic mice results in augmented APC activity and robust immune response with increased diversity of induced antibodies (Q28730212) (← links)
- Comparative Evaluation of the Chemical Stability of 4 Well-Defined Immunoglobulin G1-Fc Glycoforms (Q28820826) (← links)
- Bioconjugation of therapeutic proteins and enzymes using the expanded set of genetically encoded amino acids (Q30279245) (← links)
- Passive immunization against HIV/AIDS by antibody gene transfer. (Q30358434) (← links)
- Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform (Q30386192) (← links)
- Molecular Imaging of Pancreatic Cancer with Antibodies (Q30393523) (← links)
- A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes (Q30410546) (← links)
- Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease (Q30414837) (← links)
- Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates. (Q30422151) (← links)
- The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging (Q30559277) (← links)
- The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics (Q30566003) (← links)
- Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies (Q30818421) (← links)
- Direct quantitative 13 C-filtered 1 H magnetic resonance imaging of PEGylated biomacromolecules in vivo. (Q31077545) (← links)
- CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery. (Q31135534) (← links)
- Restoring the balance: immunotherapeutic combinations for autoimmune disease (Q33555986) (← links)
- Antibody therapeutics targeting ion channels: are we there yet? (Q33572352) (← links)
- Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma. (Q33621610) (← links)
- Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding (Q33676732) (← links)
- Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells (Q33849404) (← links)
- Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects (Q33905411) (← links)
- Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency (Q33942410) (← links)
- The promise and challenge of high-throughput sequencing of the antibody repertoire. (Q33962293) (← links)
- Target-selective joint polymerase chain reaction: a robust and rapid method for high-throughput production of recombinant monoclonal antibodies from single cells (Q33966567) (← links)
- A new strategy to deliver synthetic protein drugs: self-reproducible biologics using minicircles (Q34001530) (← links)
- Strategies and challenges for the next generation of therapeutic antibodies (Q34111699) (← links)
- Identification of Eps15 as antigen recognized by the monoclonal antibodies aa2 and ab52 of the Wuerzburg Hybridoma Library against Drosophila brain (Q34113731) (← links)
- Introduction to current and future protein therapeutics: a protein engineering perspective (Q34168363) (← links)
- In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model (Q34287387) (← links)
- Antibody therapeutics in cancer. (Q34370627) (← links)
- Structural basis of IL-23 antagonism by an Alphabody protein scaffold (Q34445379) (← links)
- Survey of monoclonal antibody disposition in man utilizing a minimal physiologically-based pharmacokinetic model (Q34484225) (← links)
- Large-scale in vitro expansion of polyclonal human switched-memory B lymphocytes (Q34532604) (← links)
- Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity (Q34575855) (← links)